This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by De Benedetti, F. Articles by Martini, A. Search for Related Content PubMed PubMed Citation Articles by De Benedetti, F. Articles by Martini, A.

Effect of IL-6 on IGF Binding Protein-3: A Study in IL-6 Transgenic Mice and in Patients with Systemic Juvenile Idiopathic Arthritis

Pediatria Generale e Reumatologia (F.D.B., C.M., M.O., P.P., M.V., A.M.), Dipartimento di Scienze Pediatriche, Instituto di Ricerca e Cura a Cattere Scientifico Policlinico San Matteo, 27100 Pavia, Italy; Dipartimento di Biotecnologie Cellulari ed Ematologia (T.A.), Sezione Genetica Molecolare, Policlinico Umberto I, 00198 Roma, Italy, IRBM P. Angeletti (E.F.), 00040 Pomezia (Roma), Italy; and Dipartimento di Scienze Endocrinologiche e Metaboliche (S.G., A.B.), Università di Genova, 16132 Genova, Italy

Address all correspondence and requests for reprints to: Alberto Martini, M.D., Professor of Pediatrics, Instituto di Ricerca e Cura a Cattare Scientifico San Matteo, Università degli Studi di Pavia, Piazzale Golgi 2, 27100 Pavia Italy. E-mail: amartini{at}smatteo.pv.it

Stunted growth is a common complication of childhood diseases characterized by chronic inflammation or infections. We previously demonstrated that NSE/hIL-6 transgenic mice, overexpressing the inflammatory cytokine IL-6 since early phase of life, showed a marked growth defect associated with decreased IGF-I levels, suggesting that IL-6 is one of the factors involved in stunted growth complicating chronic inflammation in childhood. Here we show that NSE/hIL-6 mice have normal liver IGF-I production, decreased levels of IGF binding protein-3 (IGFBP-3) and increased serum IGFBP-3 proteolysis. Reduced IGFBP-3 levels results in a marked decrease in the circulating 150-kDa ternary complex, even in the presence of normally functional acid labile subunit. Pharmacokinetic studies showed that NSE/hIL-6 mice have accelerated IGF-I clearance. Patients with systemic juvenile idiopathic arthritis (s-JIA), a chronic inflammatory disease characterized by prominent IL-6 production and complicated by stunted growth associated with low IGF-I levels, have markedly decreased IGFBP-3 levels, increased serum IGFBP-3 proteolysis and normal acid labile subunit levels. Our data show that chronic overproduction of IL-6 causes decreased IGFBP-3 levels, resulting in a decreased association of IGF-I in the 150-kDa complex. Decreased levels of IGF-I appear to be secondary to increased clearance.

This article has been cited by other articles:

				P. M. Yamada and K.-W. Lee Perspectives in mammalian IGFBP-3 biology: local vs. systemic action Am J Physiol Cell Physiol, May 1, 2009; 296(5): C954 - C976. [Abstract] [Full Text] [PDF]

				I. Hansen-Pupp, E. Engstrom, A. Niklasson, A.-C. Berg, V. Fellman, C. Lofqvist, A. Hellstrom, and D. Ley Fresh-Frozen Plasma as a Source of Exogenous Insulin-Like Growth Factor-I in the Extremely Preterm Infant J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 477 - 482. [Abstract] [Full Text] [PDF]

				P. W. Bodell, E. Kodesh, F. Haddad, F. P. Zaldivar, D. M. Cooper, and G. R. Adams Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise J Appl Physiol, February 1, 2009; 106(2): 443 - 453. [Abstract] [Full Text] [PDF]

				U Berg, T Gustafsson, C J Sundberg, L Kaijser, C Carlsson-Skwirut, and P Bang Interstitial IGF-I in exercising skeletal muscle in women Eur. J. Endocrinol., October 1, 2007; 157(4): 427 - 435. [Abstract] [Full Text] [PDF]

				W. Hernandez, C. Grenade, E. R. Santos, C. Bonilla, C. Ahaghotu, and R. A. Kittles IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans Carcinogenesis, October 1, 2007; 28(10): 2154 - 2159. [Abstract] [Full Text] [PDF]

				S. Bechtold, P. Ripperger, R. D. Pozza, W. Bonfig, R. Hafner, H. Michels, and H. P. Schwarz Growth Hormone Increases Final Height in Patients with Juvenile Idiopathic Arthritis: Data from a Randomized Controlled Study J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3013 - 3018. [Abstract] [Full Text] [PDF]

				V. E. MacRae, C. Farquharson, and S. F. Ahmed The pathophysiology of the growth plate in juvenile idiopathic arthritis Rheumatology, January 1, 2006; 45(1): 11 - 19. [Abstract] [Full Text] [PDF]

				A. R. Cappola, Q.-L. Xue, L. Ferrucci, J. M. Guralnik, S. Volpato, and L. P. Fried Insulin-Like Growth Factor I and Interleukin-6 Contribute Synergistically to Disability and Mortality in Older Women J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2019 - 2025. [Abstract] [Full Text] [PDF]